Steroid excretion in users of the injectable combined oestrogen progestogen preparation, deladroxate.
Zaki
K
K
Younis
N
N
Nour
H
H
D000463:Algestone Acetophenide; D001695:Biology; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003278:Contraceptives, Oral, Hormonal; D004703:Endocrine System; D004964:Estriol; D004967:Estrogens; D004997:Ethinyl Estradiol; D005193:Family Planning Services; D006728:Hormones; D007267:Injections; D008660:Metabolism; D010827:Physiology; D012106:Research; D013256:Steroids
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003278:Contraceptives, Oral, Hormonal; D004967:Estrogens; D006728:Hormones; D013256:Steroids; D004997:Ethinyl Estradiol; D004964:Estriol; D000463:Algestone Acetophenide
Algestone Acetophenide--administraction and dosage; Algestone Acetophenide--side effects; Biology; Clinical Research; Contraception; Contraceptive Agents, Estrogen--administraction and dosage; Contraceptive Agents, Estrogen--side effects; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--administraction and dosage; Contraceptive Agents--side effects; Endocrine System; Estriol--analysis; Estrogens; Ethinyl Estradiol--administraction and dosage; Ethinyl Estradiol--side effects; Family Planning; Hormones; Injectables; Metabolic Effects; Physiology; Research Methodology; Steroid Metabolic Effects